Trials / Completed
CompletedNCT00839267
Clopidogrel Efficacy and Acute Coronary Syndromes
The Comparison of Clopidogrel Efficacy in Patients With Acute Myocardial Infarction and Severe Hemodynamic Instability to Patients With Hemodynamically Uncomplicated Myocardial Infarction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare clopidogrel effectiveness between severe hemodynamically unstable versus stable patients with acute myocardial infarction.
Detailed description
Clopidogrel exists in oral form only. As a prodrug, it has to be metabolized to the active form by cytochrome system in the liver. Both facts could lead to lower efficacy of the drug in hemodynamically unstable patients, where splanchnic and liver hypoperfusion is present. We hypothesised that clopidogrel efficacy is insufficient in patients with acute myocardial infarction and severe hemodynamic instability. Therefore we would like to compare the effect of clopidogrel in unstable STEMI patients on mechanical ventilation with stable STEMI patients.
Conditions
Timeline
- Start date
- 2006-06-01
- Completion
- 2008-12-01
- First posted
- 2009-02-09
- Last updated
- 2009-02-10
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT00839267. Inclusion in this directory is not an endorsement.